BELANETTE 0.02 mg/3 mg, film-coated tablet 21 tablets
Active ingredients: Drospirenone, Ethinylestradiol, ÉTHINYLESTRADIOL BÉTADEX-CLATHRATE
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet21 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BELANETTE 0,02 mg/3 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 plaquette(s) PVC-Aluminium de 21 comprimé(s)
- Marketing authorisation holder
- BAYER HEALTHCARE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Jun 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64115976CIP73764181CIP133400937641814Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHINYLESTRADIOLcomprimé | 0,020 mg · un comprimé | FT |
| DROSPIRÉNONEcomprimé | 3 mg · un comprimé | SA |
| ÉTHINYLESTRADIOL BÉTADEX-CLATHRATEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.